Smoking increases risk of death for nasopharyngeal carcinoma survivors

November 19, 2013

Survivors of nasopharyngeal carcinoma who are former or current smokers are more likely to have their disease progress, relapse, or spread, and are more likely to die of their disease, compared with survivors of nasopharyngeal carcinoma who have never smoked, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

"While it is established that tobacco smoke is a risk factor for [the most common cancer arising from the upper part of the throat behind the nose and near the base of skull], its role in influencing survival of patients with established cancers is not known," said Fang-Yun Xie, M.D., professor in the Department of Radiation Oncology at the Sun Yat-sen University Cancer Center in Guangzhou, China. "We found that cigarette smoking does influence the survival of patients with nasopharyngeal carcinoma. Patients with a history of smoking, regardless of whether they ceased smoking for one or more years, have poorer survival than those who never smoked."

In the United States, about 2,900 people are expected to develop nasopharyngeal carcinoma in 2013, and about half of the people with this cancer are younger than 55 years old, according to the American Cancer Society. This cancer is more common in some parts of China.

"Our findings demonstrate the dangers of cigarette smoking in terms of the survival of patients. Hence, we strongly recommend that people, including those with nasopharyngeal carcinoma, do not smoke," said Xie.

Xie and colleagues followed 1,849 newly diagnosed nasopharyngeal carcinoma patients admitted to the Sun Yat-sen University Cancer Center between 2005 and 2007. They gathered information on smoking and drinking history, and demographics. The primary endpoint for the study was overall survival, and secondary endpoints were progression-free survival, locoregional relapse-free survival, and distant metastasis-free survival. Patients were followed for up to eight years.

During follow-up, 8 percent of the patients developed locoregional relapse, about 13 percent had their disease spread to distant organs, and 20 percent died of their disease.

The researchers found that among all nasopharyngeal carcinoma patients, those who smoked heavily were 3.3-fold more likely to die, 2.5-fold more likely to have their disease progress, and 2.7-fold more likely to have their disease spread to distant organs, compared with those who did not smoke. Both former and current smokers were impacted equally.

They also found a dose-response relationship between pack-years smoked and increase in risk of death or progression: the higher the pack-years, the lower the survival rate.

The findings were still significant in subgroup analyses and after adjusting for age, gender, drinking status, cancer subtype, tumor stage, spread of the disease, status of Epstein-Barr virus infection (which can cause this cancer), radiation techniques, and chemotherapy regimens.

"Previous studies have found that cancer patients resume smoking after treatment because of a higher perceived difficulty of quitting, and lower perceptions of their -related risk," said Xie. "Our finding that cigarette smoking lowers the chance of for nasopharyngeal carcinoma patients, with a dose-response relationship, is a key fact that the general audience should keep in mind."

Explore further: Concurrent chemo and radiation confers survival benefit in nasopharyngeal carcinoma patients

Related Stories

Concurrent chemo and radiation confers survival benefit in nasopharyngeal carcinoma patients

November 5, 2011
The combination of chemotherapy and radiation significantly improved the 5-year overall survival of patients with stage II nasopharyngeal carcinoma (NPC), according to a phase III study published Nov. 4 in the Journal of ...

Spread of nasopharyngeal carcinoma is reduced by bevacizumab, according to phase 2 trial results

December 16, 2011
The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects.

Prognosis after cystectomy not affected by smoking

October 15, 2012
(HealthDay)—Despite the link between cigarette smoking and the development of bladder cancer, the prognosis of people with bladder cancer after undergoing a cystectomy is not affected by cigarette smoking, according to ...

Smoking linked with worse urothelial cancer prognosis in patients, especially women

March 14, 2013
Smoking significantly increases individuals' risk of developing serious forms of urothelial carcinoma and a higher likelihood of dying from the disease, particularly for women. That is the conclusion of a recent study published ...

Recommended for you

New study reveals breast cancer cells recycle their own ammonia waste as fuel

October 19, 2017
Breast cancer cells recycle ammonia, a waste byproduct of cell metabolism, and use it as a source of nitrogen to fuel tumor growth, report scientists from Harvard Medical School in the journal Science.

US regulators approve 2nd gene therapy for blood cancer

October 19, 2017
U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults.

New findings explain how UV rays trigger skin cancer

October 18, 2017
Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from ...

Drug yields high response rates for lung cancer patients with harsh mutation

October 18, 2017
A targeted therapy resurrected by the Moon Shots Program at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries ...

Possible new immune therapy target in lung cancer

October 18, 2017
A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors behave abnormally. They not only inadequately support vascular structures, but ...

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.